Cancer drugs represented the lion's share of new drug approvals in 2020, with 21 novel agents expected to be approved.
In a presentation at the AMCP Nexus 2020 Virtual meeting, Aimee Tharaldson, PharmD, a senior clinical pharmacist in emerging therapeutics at Express Scripts, highlighted several important agents approved this year.
"In many cases, cancers are treated more as a chronic condition. So the number of people living with cancer is growing,” Tharaldson said. She noted that